Ignite Creation Date:
2024-05-06 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05727189
Status:
RECRUITING
Last Update Posted:
2023-11-27
First Post:
2023-01-25
Brief Title:
A Study of Idazoxan in Healthy Participants
Sponsor:
Terran Biosciences Australia Pty Ltd
Organization:
Terran Biosciences Australia Pty Ltd
Study Overview
Official Title:
A Phase 1 Safety Tolerability and Pharmacokinetic Study of R-Idazoxan HCl Extended-Release TR-01-XRR S-Idazoxan HCl Extended-Release TR-01-XRS and Racemic Idazoxan HCl Extended-Release TR-01-XR in Healthy Participants
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Four-part study of the safety tolerability and pharmacokinetics of 3 forms of TR-01-XRR 1 form of TR-01-XRS and 1 form of TR-01-XR in healthy adults
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None